Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway.

Autor: Espericueta V; Department of Biological Sciences, California State University Long Beach, CA, USA., Manughian-Peter AO; Department of Biological Sciences, California State University Long Beach, CA, USA., Bally I; Univ. Grenoble Alpes, CEA, CNRS, IBS, F-38000, Grenoble, France., Thielens NM; Univ. Grenoble Alpes, CEA, CNRS, IBS, F-38000, Grenoble, France., Fraser DA; Department of Biological Sciences, California State University Long Beach, CA, USA. Electronic address: Deborah.fraser@csulb.edu.

Publikováno v: Molecular immunology [Mol Immunol] 2020 Jan; Vol. 117, pp. 65-72. Date of Electronic Publication: 2019 Nov 15.

Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

Autor: Orozco JIJ; Cancer Epigenetics Laboratory, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Grumley JG; Margie Petersen Breast Center, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Matsuba C; Computational Biology Laboratory, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Manughian-Peter AO; Cancer Epigenetics Laboratory, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Chang SC; Medical Data Research Center, Providence Saint Joseph Health, Portland, OR, USA., Chang G; Hematology and Oncology Department, Providence Saint John's Health Center, Santa Monica, CA, USA., Gago FE; Gineco-Mamario Institute, Mendoza, Argentina., Salomon MP; Computational Biology Laboratory, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA. matthew.salomon@providence.org., Marzese DM; Cancer Epigenetics Laboratory, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, USA. marzesed@jwci.org.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2019 Oct; Vol. 26 (10), pp. 3185-3193. Date of Electronic Publication: 2019 Jul 24.

Epigenetic profiling for the molecular classification of metastatic brain tumors.

Autor: Orozco JIJ; Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Knijnenburg TA; Institute for Systems Biology, Seattle, WA, 98109, USA., Manughian-Peter AO; Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Salomon MP; Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Barkhoudarian G; Pacific Neuroscience Institute, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Jalas JR; Department of Pathology, Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, 2065, Australia., Hothi P; Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, 98122, USA., Wang X; Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Takasumi Y; Department of Pathology, Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Buckland ME; Department of Neuropathology, Royal Prince Alfred Hospital, the Brain and Mind Centre, The University of Sydney, Camperdown, NSW, 2050, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, 2065, Australia.; Sydney Medical School, The University of Sydney, Camperdown, NSW, 2006, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, 2065, Australia.; Royal North Shore Hospital, Sydney, NSW, 2065, Australia., Cobbs CS; Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, 98122, USA., Shmulevich I; Institute for Systems Biology, Seattle, WA, 98109, USA., Kelly DF; Pacific Neuroscience Institute, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, 2065, Australia.; Sydney Medical School, The University of Sydney, Camperdown, NSW, 2006, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia., Hoon DSB; Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.; Sequencing Center, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Marzese DM; Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA. MarzeseD@jwci.org.

Publikováno v: Nature communications [Nat Commun] 2018 Nov 06; Vol. 9 (1), pp. 4627. Date of Electronic Publication: 2018 Nov 06.

Alternative splicing and cancer metastasis: prognostic and therapeutic applications.

Autor: Marzese DM; Department of Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA, USA., Manughian-Peter AO; Department of Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA, USA., Orozco JIJ; Department of Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA, USA., Hoon DSB; Department of Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA, USA. hoond@jwci.org.; Sequencing Center, John Wayne Cancer Institute, Santa Monica, CA, USA. hoond@jwci.org.

Publikováno v: Clinical & experimental metastasis [Clin Exp Metastasis] 2018 Aug; Vol. 35 (5-6), pp. 393-402. Date of Electronic Publication: 2018 May 29.